Postmortem serotoninergic correlates of cognitive decline in Alzheimer??s disease
- 1 July 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in NeuroReport
- Vol. 13 (9), 1175-1178
- https://doi.org/10.1097/00001756-200207020-00021
Abstract
Serotonin1A receptor density and serotonin concentration were measured in the postmortem neocortex of 17 AD patients who had been prospectively assessed every four months with the Mini-Mental State Examination (MMSE) for a mean of 2.6 years till death. In the frontal cortex, serotonin levels correlated negatively with the annual rate of MMSE decline, while serotonin1A receptor density was positively correlated with the rate of MMSE decline. Our study suggests that reduced serotonin levels and increased serotonin1A receptor density are markers for accelerated cognitive decline in AD, and provides support for the use of serotonin1A antagonists in the treatment of AD.Keywords
This publication has 22 references indexed in Scilit:
- Natural history of behavioural changes and psychiatric symptoms in Alzheimer's diseaseThe British Journal of Psychiatry, 1999
- Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortexBrain Research, 1998
- Behaviour changes in dementia 1: Point of entry data of a prospective studyInternational Journal of Geriatric Psychiatry, 1997
- Presynaptic Serotonergic Markers in Community‐Acquired Cases of Alzheimer's Disease: Correlations with Depression and Neuroleptic MedicationJournal of Neurochemistry, 1996
- Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's diseaseNeurology, 1994
- Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic PerspectivesJournal of Neurochemistry, 1993
- Animal and drug modelling for Alzheimer synaptic pathologyProgress in Neurobiology, 1992
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Analysis of radioligand binding experiments: A collection of computer programs for the IBM PCJournal of Pharmacological Methods, 1985
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975